Reversal of human cellular senescence:: roles of the p53 and p16 pathways

被引:1093
作者
Beauséjour, CM
Krtolica, A
Galimi, F
Narita, M
Lowe, SW
Yaswen, P
Campisi, J
机构
[1] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA
[2] Salk Inst Biol Studies, La Jolla, CA 92037 USA
[3] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
[4] Buck Inst Age Res, Novato, CA 94945 USA
[5] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy
关键词
cyclin-dependent kinase; pRB; RAS; senescence; telomerase;
D O I
10.1093/emboj/cdg417
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Telomere erosion and subsequent dysfunction limits the proliferation of normal human cells by a process termed replicative senescence. Replicative senescence is thought to suppress tumorigenesis by establishing an essentially irreversible growth arrest that requires activities of the p53 and pRB tumor suppressor proteins. We show that, depending on expression of the pRB regulator p16, replicative senescence is not necessarily irreversible. We used lentiviruses to express specific viral and cellular proteins in senescent human fibroblasts and mammary epithelial cells. Expression of telomerase did not reverse the senescence arrest. However, cells with low levels of p16 at senescence resumed robust growth upon p53 inactivation, and limited growth upon expression of oncogenic RAS. In contrast, cells with high levels of p16 at senescence failed to proliferate upon p53 inactivation or RAS expression, although they re-entered the cell cycle without growth after pRB inactivation. Our results indicate that the senescence response to telomere dysfunction is reversible and is maintained primarily by p53. However, p16 provides a dominant second barrier to the unlimited growth of human cells.
引用
收藏
页码:4212 / 4222
页数:11
相关论文
共 58 条
[41]  
SAKAMOTO K, 1993, ONCOGENE, V8, P1887
[42]   A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy [J].
Schmitt, CA ;
Fridman, JS ;
Yang, M ;
Lee, S ;
Baranov, E ;
Hoffman, RM ;
Lowe, SW .
CELL, 2002, 109 (03) :335-346
[43]   Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(INK4a) [J].
Serrano, M ;
Lin, AW ;
McCurrach, ME ;
Beach, D ;
Lowe, SW .
CELL, 1997, 88 (05) :593-602
[44]   Putting the stress on senescence [J].
Serrano, M ;
Blasco, MA .
CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (06) :748-753
[45]  
Shay J W, 2001, Novartis Found Symp, V235, P116
[46]   THE FREQUENCY OF IMMORTALIZATION OF HUMAN FIBROBLASTS AND MAMMARY EPITHELIAL-CELLS TRANSFECTED WITH SV40 LARGE T-ANTIGEN [J].
SHAY, JW ;
VANDERHAEGEN, BA ;
YING, Y ;
WRIGHT, WE .
EXPERIMENTAL CELL RESEARCH, 1993, 209 (01) :45-52
[47]   A ROLE FOR BOTH RB AND P53 IN THE REGULATION OF HUMAN CELLULAR SENESCENCE [J].
SHAY, JW ;
PEREIRASMITH, OM ;
WRIGHT, WE .
EXPERIMENTAL CELL RESEARCH, 1991, 196 (01) :33-39
[48]   Cellular senescence: Mitotic clock or culture shock? [J].
Sherr, CJ ;
DePinho, RA .
CELL, 2000, 102 (04) :407-410
[49]   CDK inhibitors:: positive and negative regulators of G1-phase progression [J].
Sherr, CJ ;
Roberts, JM .
GENES & DEVELOPMENT, 1999, 13 (12) :1501-1512
[50]   ISOLATION OF A TRANSFORMING SEQUENCE FROM A HUMAN BLADDER-CARCINOMA CELL-LINE [J].
SHIH, C ;
WEINBERG, RA .
CELL, 1982, 29 (01) :161-169